Talaneh, S., Hosein zadeh, A. and Jafari, B. 2018. Treatment of advanced medullary thyroid cancer with an alternating 5 FU-dacarbazine. International Pharmacy Acta. 1, 1 (Mar. 2018), 157–158. DOI:https://doi.org/10.22037/ipa.v1i1.20501.